Torrent Pharmaceuticals Limited has announced that its amalgamation with J B Chemicals & Pharmaceuticals Limited became effective on July 8, 2026. The merger, sanctioned by the National Company Law Tribunal (NCLT), Ahmedabad Bench, on July 6, 2026, was finalized following the filing of the certified tribunal order with the Registrar of Companies. Consequently, J B Chemicals stands amalgamated into and with Torrent Pharmaceuticals and dissolved without being wound up, with the appointed date set as January 21, 2026.

The Scheme of Amalgamation outlines a share exchange ratio of 51 fully paid-up equity shares of Torrent Pharmaceuticals (face value ₹5 each) for every 100 fully paid-up equity shares of J B Chemicals (face value ₹1 each). Torrent Pharmaceuticals Limited acts as the Transferee Company, while J B Chemicals & Pharmaceuticals Limited is the Transferor Company.

Pursuant to the effectiveness of the Scheme, the capital clause of the Memorandum of Association of Torrent Pharmaceuticals has been amended. The authorized capital of the company is now ₹2,55,30,00,000 divided into 46,06,00,000 Equity Shares of ₹5 each and 25,00,000 Preference Shares of ₹100 each.

The disclosure was submitted to BSE Limited and National Stock Exchange of India Ltd in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Chintan M. Trivedi, Company Secretary of Torrent Pharmaceuticals Limited, signed the regulatory filing confirming the effective date and capital structure details.

Torrent Pharmaceuticals Limited shareholders approved a total dividend of ₹38 per equity share for the financial year ended March 31, 2026, at its 53rd Annual General Meeting held on June 23, 2026. The meeting, conducted via video conferencing, saw the adoption of standalone and consolidated financial statements and the ratification of cost auditors' remuneration. The voting results were declared by the Scrutinizer, Rajesh Parekh of RPAP & Co., confirming approval across all resolutions.

The company confirmed the payment of an interim dividend of ₹29.00 per equity share and declared a final dividend of ₹9.00 per equity share. Both dividends are applicable on shares with a fully paid-up face value of ₹5.00 each. Shareholders also ratified the remuneration of cost auditors for the fiscal year 2026-27 and approved the issuance of equity shares, which may include convertible bonds or debentures.

Voting Outcomes

The resolutions were passed through remote e-voting, which was open from June 19 to June 22, 2026, and e-voting conducted during the meeting. The proceedings were conducted in compliance with the Companies Act, 2013, and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.